Promus Element Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
FDA premarket approval P110010 · Coronary drug-eluting stent
PMA numberP110010
Approval
- Applicant
- Boston Scientific Corp
- Received
- March 28, 2011
- Decision date
- November 22, 2011 (APPR)
- Supplements
- 207, latest January 14, 2025
- Product code
- NIQ – Coronary Drug-Eluting Stent
Approval order statement
APPROVAL FOR THE PROMUS ELEMENT PLUS EVEROLIMUS-ELUTING PLATINUM CHROMIUM CORONARY STENT SYSTEM. THIS DEVICE IS INDICATED FOR IMPROVING LUMINAL DIAMETER IN PATIENTS WITH SYMPTOMATIC HEART DISEASE DUE TO DE NOVO LESIONS IN NATIVE CORONARY ARTERIES >=2.25 MM TO <=4.00 MM IN DIAMETER IN LESIONS <=28 MM INLENGTH.